Dominick Colangelo

EVP Corporate Dev & Operations, Genome Therapeutics Corporation.

Companies

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

  • Vericel VCEL312,446 shares4$12.8M at $41.02Feb 24, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

  • Feb 24, 2026Shares withheld for tax 8,824 shares at $38.09 of Vericel4
  • Feb 24, 2026Exercised options 18,250 shares of Vericel4
  • Feb 24, 2026Exercised options 18,250 shares of Vericel4
  • Feb 18, 2026Shares withheld for tax 5,657 shares at $37.41 of Vericel5
  • Feb 18, 2026Exercised options 11,700 shares of Vericel5
  • Feb 18, 2026Exercised options 18,250 shares of Vericel5
  • Jun 30, 2025Granted 123 shares at $36.17 of Vericel6
  • May 15, 2025Sold 14,063 shares at $41.53 of Vericel7
  • May 15, 2025Exercised options 14,063 shares at $2.65 of Vericel7
  • May 14, 2025Sold 14,062 shares at $42.25 of Vericel7
  • May 14, 2025Exercised options 14,062 shares at $2.65 of Vericel7
  • Apr 10, 2025Sold 24,850 shares at $41.89 of Vericel8
  • Apr 10, 2025Exercised options 24,850 shares at $2.75 of Vericel8
  • Apr 9, 2025Sold 24,850 shares at $41.11 of Vericel8
  • Apr 9, 2025Exercised options 24,850 shares at $2.75 of Vericel8
  • Mar 13, 2025Sold 26,592 shares at $45.78 of Vericel9
  • Mar 13, 2025Exercised options 26,592 shares at $1.95 of Vericel9
  • Mar 12, 2025Sold 26,591 shares at $46.31 of Vericel9
  • Mar 12, 2025Exercised options 26,591 shares at $1.95 of Vericel9
  • Feb 24, 2025Shares withheld for tax 8,459 shares at $52.33 of Vericel10
  • Feb 24, 2025Exercised options 18,250 shares of Vericel10
  • Feb 19, 2025Shares withheld for tax 4,196 shares at $57.78 of Vericel11
  • Feb 19, 2025Exercised options 8,938 shares of Vericel11
  • Feb 18, 2025Shares withheld for tax 5,423 shares at $57.28 of Vericel11
  • Feb 18, 2025Exercised options 11,700 shares of Vericel11